Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2590-2595

  Schaefer, Betti ^a   Schlosser, Katja ^b   Wühl, Elke ^a   Schall, Petra ^a   Klaus, Günter ^c   Schaefer, Franz ^a   Schmitt, Claus Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c KfH Pediatric Kidney Center   (Germany)

Author keywords

children; chronic kidney disease; hyperparathyroidism; parathyroidectomy; renal transplantation

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HORMONE METABOLISM; HUMAN; HYPOCALCEMIA; LONG TERM CARE; MALE; NERVE PARALYSIS; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PEDIATRICS; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SEIZURE; VITAMIN SUPPLEMENTATION; BONE DISEASES; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMPLICATION; HYPERPARATHYROIDISM; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; METABOLISM; PROGNOSIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; BONE DISEASES; CALCIUM; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HUMANS; HYPERPARATHYROIDISM; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; PARATHYROID HORMONE; PARATHYROIDECTOMY; PHOSPHATES; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77954775628     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq074     Document Type: Article

References (50)

1. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
2. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
3. Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O. Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 2003; 18: 440-444 (Pubitemid 36798487)
4. Muscheites J, Wigger M, Drueckler E, Fisher DC, Kundt G, Haffner D. Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol 2008; 23: 1823-1829
5. Silverstein DM, Kher KK, Moudgil A, Kuhrana M, Wilcox J, Moulan K. Cinacalcet is efficacious in pediatric dialysis patients. Pediatr Nephrol 2008; 23: 1817-1822
6. Wu S, Palese T, Mishra OP, Delivoria-Papadopoulos M, De Luca F. Effects of Ca2+ sensing receptor activation in the growth plate. FASEB J 2004; 18: 143-145
7. Nakagawa K, Perez EC, Oh J et al. Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia. Nephrol Dial Transplant 2008; 23: 2761-2767
8. Ghanekar H, Welch BJ, Moe OW, Sakhaee K. Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens 2006; 15: 97-104
9. Koch Nogueira PC, Rey N, Said MH, Cochat P. Evolution of hyperparathyroidism after renal transplantation in children-effect of pre-emptive transplantation and duration of dialysis. Nephrol Dial Transplant 1997; 12: 984-987
10. Matsuda-Abedini M, Portale AA, Shah A, Neuhaus J, McEnhill M, Matias RS. Persistent secondary hyperparathyroidism after renal transplantation in children. Pediatr Nephrol 2006; 21: 413-418
11. Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991; 15: 745-750
12. Berard E, Crosca G, Broyer M, Fekete C, Kenesi M, Dechaux M. Parathyroidectomy in children with renal failure. Retrospective study of 17 cases. Arch Fr Pediatr 1989; 46: 417-424
13. Schlosser K, Schmitt CP, Bartholomaeus JE et al. Parathyroidectomy for renal hyperparathyroidism in children and adolescents. World J Surg 2008; 32: 801-806
14. Klaus G, Watson A, Edefonti A et al. European Pediatric Dialysis Working Group (EPDWG) Prevention and treatment of renal osteo- dystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 2006; 21: 151-159
15. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Disease 2005; 46
16. Groothoff JW, Offringa M, van Eck-Smit BLF et al. Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int 2003; 63: 266-275
17. De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM. The severity of secondary hyperparathyroidism in chronic renal insuffi ciency is GFR-dependent, race-dependent, and associated with cardio- 3 vascular disease. J Am Soc Nephrol 2002; 13: 2762-2769
18. Litwin M, Wuhl E, Jourdan C et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16: 1494-1500
19. Shroff RC, Donald AE, Hiorns MP et al. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 2007; 18: 2996-3003
20. Mazzaferro S, Pasquali M, Farcomeni A et al. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQITM ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 2008; 23: 2319-2323
21. Waller SC, Ridout D, Cantor T, Rees L. Parathyroid hormone and growth in children with chronic renal failure. Kidney Int 2005; 67: 2338-2345 (Pubitemid 41623395)
22. Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-1819
23. Rodriguez-Ayala E, Avila-Diaz M, Foyo-Niembro E, Amato D, Ramirez-San-Juan E, Paniagua R. Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone. Nephron Physiol 2006; 103: 112-118
24. Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT. Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006; 290: 286-294
25. Bleyer AJ, Burkart J, Piazza M, Russel G, Rohr M, Carr JJ. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis 2005; 46: 464-469
26. Maeda H, Tokumoto M, Yotsueda H et al. Two cases of calciphylaxis treated by parathyroidectomy: importance of increased bone formation. Clin Nephrol 2007; 67: 397-402
27. Yeh SM, Hwang SJ, Chen HC. Treatment of severe metastatic calcification in hemodialysis patients. Hemodial Int 2009; 13: 163-167
28. Sato S, Ohta M, Kawaguchi Y et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 1995; 21: 67-71
29. Koc O, Nart A, Dogan M, Yildirim Y, Ozbakkaloglu M, Uslu A. Impact of subtotal parathyroidectomy and in situ preservation of the remnant on the metabolic and cardiac manifestations of secondary hyperparathyreoidism. Transplant Proc 2002; 34: 2046-2048
30. Goto N, Tominaga Y, Matsuoka S et al. Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol 2005; 9: 138-141
31. de Sevaux RGL, Hoitsma AJ, van Hoof HJC, Corstens FJM, Wetzels JFM. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Clin Pract 2003; 93: 21-28
32. Akaberi S, Lindergard B, Simonsen O, Nyberg G. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 2006; 82: 749-752
33. Lee PP, Schiffmann L, Offermann G, Beige J. Effects of parathyroid- ectomy on renal allograft survival. Kidney Blood Press Res 2004; 27: 191-196
34. Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single center study. Nephrol Dial Transplant 2005; 20: 1714-1720
35. Garcia A, Mazuecos A, Garcia T, Gonzales P, Ceballos M, Rivero M. Effect of parathyroidectomy on renal graft function. Transplant Proc 2005; 37: 1459-1461
36. Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 2007; 22: 584-591
37. Chou FF, Hsieh KC, Chen YT, Lee CT. Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism. Transplantation 2008; 86: 554-557
38. Ardissino G, Schmitt CP, Testa S, Claris-Appiani A, Mehls O. Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure. Pediatr Nephrol 2000; 14: 664-668
39. Chow TL, Chan TT, Ho YW, Lam SH. Improvement of anemia after parathyroidectomy in chinese patients with renal failure undergoing long-term dialysis. Arch Surg 2007; 142: 644-648
40. Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery 2008; 144: 915-919
41. Coen G, Calabria S, Bellinghieri G et al. Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia. Nephron 2001; 88: 149-155
42. Goldsmith DJ, Covic AA, Venning MC, Ackrill P. Blood pressure reduction after parathyroidectomy for secondary hyperparathyroid- ism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis 1996; 27: 819-825
43. Kosch M, Hausberg M, Barenbrock M, Posadzy-Malaczynska A, Kister K, Rahn KH. Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clin Nephrol 2001; 55: 303-308
44. Almirall J, Lopez T, Comerma I, Garcia E, Marques C. Effect of para- thyroidectomy on blood pressure in dialysis patients. Nephron 2002; 92: 495-496
45. Ifudu O, Matthew JJ, Macey LJ et al. Parathyroidectomy does not correct hypertension in patients on maintenance hemodialysis. Am J Nephrol 1998; 18: 28-34
46. Drueke TB, Eckardt KU. Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients. Nephrol Dial Transplant 2002; 17: 28-31
47. Moe SM, Cunningham J, Bommer J et al. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCI. Nephrol Dial Transplant 2005; 20: 2186-2193
48. Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 2006; 18: 6254
49. EMEA. European Assessment Report MIMPARA. Available at: http://wwwemeaeuropaeu/humandocs/PFDs/EPAR/mimpara/12029804en6pdf
50. Bacchetta J, Plotton I, Ranchin B et al. Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism. Nephrol Dial Transplant 2009; 24: 2595-2598